소장자료
LDR | 02224cam a2200325ia 4500 | ||
001 | 0009304995▲ | ||
005 | 20180519121352▲ | ||
008 | 051214s2005 sz a b i100 0 eng d▲ | ||
020 | ▼a 9241209291▲ | ||
035 | ▼a (KERIS)BIB000010427195▲ | ||
040 | ▼aFQG▼cFQG▼dVP@▼dBAKER▼d224010▼d211009▼d221016▲ | ||
082 | 0 | 4 | ▼a 615.19 ▼2 21▲ |
090 | ▼a 615.19 ▼b W628w▲ | ||
111 | 2 | ▼a WHO Expert Committee on Specifications for Pharmaceutical Preparations▼n (39th :▼d 2004 :▼c Geneva, Switzerland)▲ | |
245 | 1 | 0 | ▼aWHO Expert Committee on Specifications for Pharmaceutical Preparations :▼bthirty-ninth report.▲ |
260 | ▼aGeneva:▼bWorld Health Organization,▼c2005.▲ | ||
300 | ▼avii, 142 p.:▼bill.;▼c24 cm.▲ | ||
440 | 0 | ▼aWHO technical report series,▼x0512-3054;▼v929▲ | |
500 | ▼a "WHO Expert Committee on Specifications for Pharmaceutical Preparations, Geneva, 25-29 October 2004"--P. v.▲ | ||
504 | ▼a Includes bibliographical references.▲ | ||
520 | ▼a This report discusses the monographs on antiretrovirals proposed for inclusion in The International Pharmacopoeia and specifications for radiopharmaceuticals, quality specifications for antituberculosis drugs and the revision of the monograph on artemisinin derivatives, as well as quality control of reference materials, good manufacturing practices, inspection, distribution and trade, and other aspects of quality assurance of pharmaceuticals, and regulatory issues. Several annexes include an amendment to good manufacturing practices: main principles regarding the requirement for the sampling of starting materials, guidelines on good manufacturing practices regarding water for pharmaceutical use, guidelines on the sampling of pharmaceutical products, and draft guidelines for registration of fixed-dose combination medicinal products.▲ | ||
650 | 0 | ▼a Drugs▼x Standards▼v congresses.▲ | |
650 | 0 | ▼a Pharmacopoeias▼v congresses.▲ | |
650 | 0 | ▼a Drugs▼x Quality control▼v congresses.▲ | |
650 | 0 | ▼a Pharmaceutical preparations▼x standards▲ | |
650 | 0 | ▼a Technology, Pharmaceutical▼x standards▲ | |
650 | 0 | ▼a Drug industry▲ | |
710 | 2 | ▼a World Health Organization.▲ | |
830 | 0 | ▼aTechnical report series (World Health Organization);▼v929.▲ | |
990 | ▼a 정영주▼b정영주▲ |

WHO Expert Committee on Specifications for Pharmaceutical Preparations :thirty-ninth report
자료유형
국외단행본
서명/책임사항
WHO Expert Committee on Specifications for Pharmaceutical Preparations : thirty-ninth report.
회의명
WHO Expert Committee on Specifications for Pharmaceutical Preparations, (39th, : 2004, : Geneva, Switzerland)
발행사항
Geneva : World Health Organization , 2005.
형태사항
vii, 142 p. : ill. ; 24 cm.
총서사항
WHO technical report series , 0512-3054 ; 929
Technical report series (World Health Organization) ; 929.
Technical report series (World Health Organization) ; 929.
일반주기
"WHO Expert Committee on Specifications for Pharmaceutical Preparations, Geneva, 25-29 October 2004"--P. v.
서지주기
Includes bibliographical references.
요약주기
This report discusses the monographs on antiretrovirals proposed for inclusion in The International Pharmacopoeia and specifications for radiopharmaceuticals, quality specifications for antituberculosis drugs and the revision of the monograph on artemisinin derivatives, as well as quality control of reference materials, good manufacturing practices, inspection, distribution and trade, and other aspects of quality assurance of pharmaceuticals, and regulatory issues. Several annexes include an amendment to good manufacturing practices: main principles regarding the requirement for the sampling of starting materials, guidelines on good manufacturing practices regarding water for pharmaceutical use, guidelines on the sampling of pharmaceutical products, and draft guidelines for registration of fixed-dose combination medicinal products.
주제
ISBN
9241209291
청구기호
615.19 W628w
소장정보
예도서예약
서서가에없는책 신고
보보존서고신청
캠캠퍼스대출
우우선정리신청
배자료배달신청
문문자발송
출청구기호출력
학소장학술지 원문서비스
등록번호 | 청구기호 | 소장처 | 도서상태 | 반납예정일 | 서비스 |
---|
북토크
자유롭게 책을 읽고
느낀점을 적어주세요
글쓰기
느낀점을 적어주세요
청구기호 브라우징
관련 인기대출 도서